Interestingly, re-analyses of publicly available RNA expression data from patient cohorts with early-stage and locally advanced lung adenocarcinoma revealed that time-to-first-progression and overall survival were significantly reduced in patients with tumors exhibiting low AHR expression (Fig. 1d, Supplementary Fig. 1a). Here, AHR is linked to lung adenocarcinoma.